Canada markets closed
  • S&P/TSX

    20,287.80
    -24.00 (-0.12%)
     
  • S&P 500

    4,395.26
    -23.89 (-0.54%)
     
  • DOW

    34,935.47
    -149.03 (-0.42%)
     
  • CAD/USD

    0.8017
    -0.0002 (-0.02%)
     
  • CRUDE OIL

    73.23
    -0.72 (-0.97%)
     
  • BTC-CAD

    49,578.13
    -3,401.25 (-6.42%)
     
  • CMC Crypto 200

    962.76
    +12.86 (+1.35%)
     
  • GOLD FUTURES

    1,807.10
    -5.50 (-0.30%)
     
  • RUSSELL 2000

    2,226.25
    -13.78 (-0.62%)
     
  • 10-Yr Bond

    1.2390
    -1.2390 (-100.00%)
     
  • NASDAQ futures

    15,028.50
    +72.75 (+0.49%)
     
  • VOLATILITY

    18.24
    -17.70 (-100.00%)
     
  • FTSE

    7,032.30
    -46.12 (-0.65%)
     
  • NIKKEI 225

    27,807.06
    +523.47 (+1.92%)
     
  • CAD/EUR

    0.6751
    -0.0001 (-0.01%)
     

Company News for Jun 11, 2021

·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Shares of Signet Jewelers Limited SIG jumped 14% after the company reported first-quarter fiscal 2022 earnings of $2.23 per share, beating the Zacks Consensus Estimate of $1.41.

  • Xinyuan Real Estate Co., Ltd.’s XIN shares surged 14% after the company highlighted completion of five newly constructed properties.

  • Shares of Verona Pharma plc VRNA jumped 13.2% after the company announced that it has entered into an agreement to develop and commercialize ensifentrine in Greater China with Nuance Pharma.

  • Pfizer Inc.’s PFE shares rose 2.2% after a news highlighted that the United States would pay the drugmaker about $3.5 billion for 500 million COVID-19 vaccine doses, to donate to the 100 lowest income countries.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Pfizer Inc. (PFE) : Free Stock Analysis Report
 
Signet Jewelers Limited (SIG) : Free Stock Analysis Report
 
Xinyuan Real Estate Co Ltd (XIN): Free Stock Analysis Report
 
Verona Pharma PLC American Depositary Share (VRNA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting